You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ADIL Award Disclosure
Davidson Matt · SEC Form 4 · Filed Jun 16, 2026
Award
Reported value range
Not reported
Davidson Matt Chief Development Officer
ADIL
Transaction date
Jun 11, 2026
Public filing date
Jun 16, 2026
Filing lag
Filed 5 days later
ADIL daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Series A Preferred Stock
- Quantity / price
- 101.3 shares
- SEC ownership
- Indirect
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001213900-26-069037
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Adial Pharmaceuticals, Inc. ADIL | Award | Jun 12, 2026 | $0 |
| Adial Pharmaceuticals, Inc. ADIL | Award | Jun 12, 2026 | $0 |
| Adial Pharmaceuticals, Inc. ADIL | Award | Jun 11, 2026 | Not reported |
| Adial Pharmaceuticals, Inc. ADIL | Award | Jun 11, 2026 | Not reported |
| Adial Pharmaceuticals, Inc. ADIL | Award | Jun 11, 2026 | Not reported |
| Adial Pharmaceuticals, Inc. ADIL Current | Award | Jun 11, 2026 | Not reported |